Biopharma companies are increasingly turning to artificial intelligence (AI) to enhance customer-focused commercial strategies, driving more tailored engagement and improved operational eff
In 2020, commercial leadership at EVERSANA, well versed in the transformation of the contract research organisation (CRO) sector, believed that the often slow-to-pivot pharmaceutical indust
Established brands represent the majority of portfolios across pharma’s global affiliates that are often neglected, with revenue and profit growth untapped.